Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

類似資料

• Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment.
  著者:: Palittiya Sintusek, 等
  出版事項: (2016-01-01)
• Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
  著者:: Sintusek, Palittiya, 等
  出版事項: (2016)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  著者:: Haiyan Zhou, 等
  出版事項: (2020-10-01)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  著者:: Zhou, Haiyan, 等
  出版事項: (2020)
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
  著者:: Catapano, Francesco, 等
  出版事項: (2016)